Ernexa Therapeutics Inc. (ERNAW) SEC Filings — 2025
16 SEC filings for Ernexa Therapeutics Inc. (ERNAW) in 2025.
Filings
- Ernex Therapeutics Files 8-K — 8-K · Dec 11, 2025
- Ernexa Narrows Losses, Raises Capital Amid Going Concern Doubts — 10-Q · Nov 7, 2025
- Ernexa's Cash Boosted by Private Placement Amid Going Concern Doubts — 10-Q · Aug 13, 2025
- Ernexia Therapeutics Changes Certifying Accountant — 8-K · Jul 7, 2025
- Ernexia Therapeutics Files 8-K with Amendments and Exhibits — 8-K · Jun 12, 2025
- Ernex Therapeutics Files 8-K on Equity Sales — 8-K · Jun 9, 2025
- Ernexia Therapeutics Files 8-K on Corporate Matters — 8-K · Jun 2, 2025
- Ernexia Therapeutics Files Q1 2025 10-Q — 10-Q · May 7, 2025
- Ernexa Therapeutics Inc. Files 2024 Annual Proxy Statement — DEF 14A · Apr 14, 2025
- Eterna Therapeutics Files 8-K: Material Agreement, Equity Sales — 8-K · Apr 3, 2025
- Eterna Therapeutics Files 8-K for Bylaws and Financials — 8-K · Mar 26, 2025
- Eterna Therapeutics Enters Material Definitive Agreement — 8-K · Mar 24, 2025
- Eterna Therapeutics Files 2024 10-K — 10-K · Mar 12, 2025
- Eterna Therapeutics Files 8-K on Shareholder Nominations — 8-K · Feb 13, 2025
- Eterna Therapeutics Faces Nasdaq Delisting, Board Changes — 8-K · Jan 10, 2025
- Eterna Therapeutics Faces Delisting Concerns — 8-K · Jan 3, 2025